How much funding has Azalea Therapeutics raised?

Azalea Therapeutics has raised $82.0M in total funding, most recently a Series A round.

When was Azalea Therapeutics founded?

Azalea Therapeutics was founded in 2023.

Where is Azalea Therapeutics headquartered?

Azalea Therapeutics is headquartered in Berkeley, California, United States.

What industry is Azalea Therapeutics in?

Azalea Therapeutics operates in Biotech, Healthcare.

How many employees does Azalea Therapeutics have?

Azalea Therapeutics has 1-10 employees.

Azalea Therapeutics

Q: Who are Azalea Therapeutics's investors?

Azalea Therapeutics's investors include Third Rock Ventures, RA Capital Management, Sozo Ventures, Yosemite.

Redefining precision genomic medicines, in vivo

Berkeley, United States · Founded 2023 · $82.0M raised

Biotech

Healthcare

Headquarters: Berkeley, California
Employees: 1–10
Founded: 2023
Business Model: B2B

Website: azaleatx.com
Total Funding: $82.0M
Last Round: $65.0M Series ANov 2025
Rounds: 2

About

Azalea Therapeutics is a Berkeley-based biotechnology company redefining precision genomic medicines in vivo, spun out of Jennifer Doudna's UC Berkeley lab. The company is pioneering proprietary Enveloped Delivery Vehicles (EDVs) that selectively locate T cells inside the body and deliver genome-editing cargo to a precise genomic locus, turning a patient's own T cells into cancer immunotherapies without removing cells for lab manipulation. Azalea launched in November 2025 with $82 million in financing.

Summary

Azalea Therapeutics is a Biotech company based in Berkeley, United States, founded in 2023. It has raised $82.0M in total across 2 rounds, most recently a $65.0M Series A round in Nov 2025. Investors include Third Rock Ventures, RA Capital Management and Sozo Ventures.